Tg Therapeutics Stock Alpha and Beta Analysis
| TGTX Stock | USD 35.07 0.52 1.51% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as TG Therapeutics. It also helps investors analyze the systematic and unsystematic risks associated with investing in TG Therapeutics over a specified time horizon. Remember, high TG Therapeutics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to TG Therapeutics' market risk premium analysis include:
Beta 2.14 | Alpha 0.35 | Risk 4.17 | Sharpe Ratio 0.16 | Expected Return 0.66 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
TGTX |
TG Therapeutics Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. TG Therapeutics market risk premium is the additional return an investor will receive from holding TG Therapeutics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in TG Therapeutics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate TG Therapeutics' performance over market.| α | 0.35 | β | 2.14 |
TG Therapeutics expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of TG Therapeutics' Buy-and-hold return. Our buy-and-hold chart shows how TG Therapeutics performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.TG Therapeutics Market Price Analysis
Market price analysis indicators help investors to evaluate how TG Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading TG Therapeutics shares will generate the highest return on investment. By understating and applying TG Therapeutics stock market price indicators, traders can identify TG Therapeutics position entry and exit signals to maximize returns.
TG Therapeutics Return and Market Media
The median price of TG Therapeutics for the period between Sat, Aug 24, 2024 and Fri, Nov 22, 2024 is 23.94 with a coefficient of variation of 12.27. The daily time series for the period is distributed with a sample standard deviation of 3.05, arithmetic mean of 24.89, and mean deviation of 2.22. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | CNH Industrial, Parsons and more join SP MidCap 400 | 09/09/2024 |
2 | Acquisition by Charney Laurence N of 22250 shares of TG Therapeutics subject to Rule 16b-3 | 09/13/2024 |
3 | XTX Topco Ltd Makes New Investment in TG Therapeutics, Inc. - MarketBeat | 09/26/2024 |
4 | Acquisition by Power Sean A of 85000 shares of TG Therapeutics subject to Rule 16b-3 | 10/17/2024 |
5 | TG Therapeutics gives mixed Q3 results, gives FY outlook | 11/04/2024 |
6 | TG Therapeutics Third Quarter 2024 Earnings Revenues Beat Expectations, EPS Lags | 11/05/2024 |
7 | Optimistic Investors Push TG Therapeutics, Inc. Shares Up 27 percent But Growth Is Lacking | 11/07/2024 |
8 | Disposition of 5000 shares by Charney Laurence N of TG Therapeutics subject to Rule 16b-3 | 11/12/2024 |
9 | Insider Sale Director Laurence Charney Sells 25,000 Shares of TG Therapeutics Inc | 11/13/2024 |
10 | Salesforce, Google sway market cap stock movers on Thursday | 11/21/2024 |
About TG Therapeutics Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including TGTX or other stocks. Alpha measures the amount that position in TG Therapeutics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2023 | 2024 (projected) | Dividend Yield | 4.28E-4 | 4.06E-4 | Price To Sales Ratio | 10.38 | 9.86 |
TG Therapeutics Upcoming Company Events
As portrayed in its financial statements, the presentation of TG Therapeutics' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, TG Therapeutics' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of TG Therapeutics' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of TG Therapeutics. Please utilize our Beneish M Score to check the likelihood of TG Therapeutics' management manipulating its earnings.
| 27th of February 2024 Upcoming Quarterly Report | View | |
| 6th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 27th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with TG Therapeutics
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for TGTX Stock Analysis
When running TG Therapeutics' price analysis, check to measure TG Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TG Therapeutics is operating at the current time. Most of TG Therapeutics' value examination focuses on studying past and present price action to predict the probability of TG Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TG Therapeutics' price. Additionally, you may evaluate how the addition of TG Therapeutics to your portfolios can decrease your overall portfolio volatility.